Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

5
results for

"Sang Soo Lee"

Article category

Keywords

Publication year

"Sang Soo Lee"

Original Articles

Acute liver injury and Acute liver failure

Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong, on Behalf of the Korean Acute-onChronic Liver Failure (KACLiF) Study Group
Clin Mol Hepatol 2020;26(4):540-553.
Published online September 17, 2020
DOI: https://doi.org/10.3350/cmh.2020.0034
Background/Aims
This study examined the risk factors associated with mortality in cirrhotic patients hospitalized with variceal bleeding, and evaluated the effects of acute-on-chronic liver failure (ACLF) on the prognosis of these patients.
Methods
This study was retrospectively conducted on patients registered in the Korean acute-on-chronic liver failure study cohort, and on 474 consecutive cirrhotic patients hospitalized with variceal bleeding from January 2013 to December 2013 at 21 university hospitals. ACLF was defined as described by the European Association for the Study of Liver-Chronic Liver Failure Consortium.
Result
s: Among a total of 474 patients, 61 patients were diagnosed with ACLF. The cumulative overall survival (OS) rate was lower in the patients with ACLF than in those without (P<0.001), and patients with higher ACLF grades had a lower OS rate (P<0.001). The chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score was identified as a significant prognostic factor in patients hospitalized with variceal bleeding (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.30–1.50; P<0.001), even in ACLF patients with variceal bleeding (HR, 1.32; 95% CI, 1.19–1.46, P<0.001). Concerning the prediction of the mortality risk at 28- and 90-day using CLIF-SOFA scores, c-statistics were 0.895 (95% CI, 0.829–0.962) and 0.897 (95% CI, 0.842–0.951), respectively, and the optimal cut-off values were 6.5 and 6.5, respectively.
Conclusions
In cirrhotic patients hospitalized with variceal bleeding, the prognosis was poor when accompanied by ACLF, especially depending upon CLIF-SOFA score. CLIF-SOFA model well predicted the 28-day or 90-day mortality for cirrhotic patients who experienced variceal bleeding.

Citations

Citations to this article as recorded by  Crossref logo
  • A Systematic Review and Meta-analysis on CLIF-C ACLF Score in Predicting Short-term Mortality in Patients with Acute on Chronic Liver Failure
    Sugan Panneerselvam, Jayakrishna Pamarthi, Joy Varghese, Rajesh Nanda, Janardanan S. Kumar, Madhumitha Haridoss
    Journal of Clinical and Experimental Hepatology.2026; 16(1): 103193.     CrossRef
  • Predicting the gastrointestinal bleeding of HBV-related acute-on-chronic liver failure based on machine learning
    Jiwei Fu, Ahao Wu, Ziwei Zhou, Ting Deng, Pei Shi, Wentao Zhu, Mengyu Tao, Yuyu Zeng, Yuchen Peng, Yuna Wang, Xiaoping Wu
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32
    Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong-Ju Yoo, Baek Gyu Jun, Sung Won Lee, Jung Gil Park, Ji Won Park, Sung-Eun Kim, Tae Yeob Kim, Soung Won Jeong, Ki Tae Suk, Moon You
    Hepatology International.2024; 18(2): 500.     CrossRef
  • Acute-on-Chronic Liver Failure: Causes, Clinical Parameters, and Predictors of Mortality
    Fatima Hafsa, Zao Iman Chaudary, Owais Tariq, Zainab Riaz, Aamir Shehzad, Muhammad Irfan Jamil, Iqra Naeem
    Cureus.2024;[Epub]     CrossRef
  • Non-invasive predictors of the first episode of bleeding from esophageal varices in patients with liver cirrhosis awaiting transplantation
    V. L. Korobka, Yu. V. Khoronko, V. D. Pasechnikov, R. V. Korobka, M. V. Malevanny, E. S. Pak, D. V. Pasechnikov
    Transplantologiya. The Russian Journal of Transplantation.2024; 16(4): 507.     CrossRef
  • Hemorragia de vías digestivas altas analizadas en pacientes con cirrosis hepática alcohólica en Boyacá (Colombia)
    Alexander German Ponce-Esparza, Fabián Andrés Sánchez-Castillo, Mariana Rada-Rada, Juliana Noguera-Fonseca, Laura Daniela Pinzón-Rodríguez, Tania Julieth Ávila-Espitia
    Revista Investigación en Salud Universidad de Boyacá.2024; 11(1): 45.     CrossRef
  • Risk stratification based on acute-on-chronic liver failure in cirrhotic patients hospitalized for acute variceal bleeding
    Zongyi Zhu, Huiqing Jiang
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • External validation of Chronic Liver Failure-Consortium Acute Decompensation score in the risk stratification of cirrhotic patients hospitalized with acute variceal bleeding
    Zongyi Zhu, Huiqing Jiang
    European Journal of Gastroenterology & Hepatology.2023; 35(3): 302.     CrossRef
  • Development and validation of a practical prognostic nomogram for evaluating inpatient mortality of cirrhotic patients with acute variceal hemorrhage
    Jie Chen, Sha Luo, Feng Tang, Ming Han, Jie Zheng, Mingming Deng, Gang Luo
    Annals of Hepatology.2023; 28(3): 101086.     CrossRef
  • Diagnosis and Management of Esophagogastric Varices
    Socrate Pallio, Giuseppinella Melita, Endrit Shahini, Alessandro Vitello, Emanuele Sinagra, Barbara Lattanzi, Antonio Facciorusso, Daryl Ramai, Marcello Maida
    Diagnostics.2023; 13(6): 1031.     CrossRef
  • Acute-on-chronic liver failure is independently associated with higher mortality for cirrhotic patients with acute esophageal variceal hemorrhage: Retrospective cohort study
    Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost Jr, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balb
    World Journal of Clinical Cases.2023; 11(17): 4003.     CrossRef
  • Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence
    Cristina Maria Marginean, Denisa  Pirscoveanu, Mihaela Popescu, Corina Maria Vasile, Anca Oana Docea, Radu Mitruț, Iulia Cristina Mărginean, George Alexandru Iacob, Dan Mihai Firu, Paul Mitruț
    Biomedicines.2023; 11(7): 1840.     CrossRef
  • To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure
    Wenyi Gu, Markus Kimmann, Wim Laleman, Michael Praktiknjo, Jonel Trebicka
    Seminars in Liver Disease.2023; 43(02): 189.     CrossRef
  • Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
    Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Diagnostics.2022; 12(2): 441.     CrossRef
  • Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding
    Victoria T. Mücke, Kai-Henrik- Peiffer, Johanna Kessel, Katharina M. Schwarzkopf, Jörg Bojunga, Stefan Zeuzem, Fabian Finkelmeier, Marcus M. Mücke, Pavel Strnad
    PLOS ONE.2022; 17(5): e0268638.     CrossRef
  • Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
    Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi
    Clinical and Molecular Hepatology.2022; 28(3): 540.     CrossRef
  • Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomy
    Fuchen Liu, Xinggang Guo, Wenli Zhang, Minghao Zou, Jian Huang, Wei Dong, Jinmin Zhang, Xiuli Zhu, Zeya Pan, Wan Yee Lau, Weiping Zhou, Hui Liu
    Portal Hypertension & Cirrhosis.2022; 1(2): 90.     CrossRef
  • Clinical Features of Hepatitis C Virus-related Acute-on-chronic Liver Failure in a Korean Population
    Jung Woo Choi, Ji Yoon Kwak, Sang Soo Lee, Hyun-gyu Kim, Ho Jin Son, Hankyu Jeon, Hee Jin Kim, Ra Ri Cha, Jae Min Lee, Hyun Jin Kim
    The Korean Journal of Gastroenterology.2022; 80(4): 169.     CrossRef
  • Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study
    Tongluk Teerasarntipan, Kessarin Thanapirom, Sakkarin Chirapongsathorn, Tanita Suttichaimongkol, Naichaya Chamroonkul, Chalermrat Bunchorntavakul, Sith Siramolpiwat, Siwaporn Chainuvati, Abhasnee Sobhonslidsuk, Apinya Leerapun, Teerha Piratvisuth, Wattana
    PLOS ONE.2022; 17(11): e0277959.     CrossRef
  • New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
    Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
    Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
  • CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review
    Ebrahim Rashed, Jonathan Soldera
    World Journal of Hepatology.2022; 14(12): 2025.     CrossRef
  • Acute‐on‐chronic liver failure due to infarction of multiple cirrhotic nodules
    Ji Won Han, Jong Young Choi, Pil Soo Sung
    Liver International.2021; 41(8): 1954.     CrossRef
  • Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
    Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
  • External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
    Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
  • β-blockers in advanced cirrhosis: More friend than enemy
    Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
    Clinical and Molecular Hepatology.2021; 27(3): 425.     CrossRef
  • Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
    Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
  • Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?
    Nae-Yun Heo
    Clinical and Molecular Hepatology.2020; 26(4): 487.     CrossRef
  • 12,219 View
  • 218 Download
  • 27 Web of Science
  • Crossref

Hepatic neoplasm

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol 2017;23(2):160-169.
Published online May 16, 2017
DOI: https://doi.org/10.3350/cmh.2016.0088
Background/Aims
Little is known about the treatment or outcomes of hepatocellular carcinoma (HCC) complicated with bile duct invasion.
Methods
A total of 247 consecutive HCC patients with bile duct invasion at initial diagnosis were retrospectively included.
Result
s: The majority of patients had Barcelona Clinic Liver Cancer (BCLC) stage C HCC (66.8%). Portal vein tumor thrombosis was present in 166 (67.2%) patients. Median survival was 4.1 months. Various modalities of treatment were initially employed including surgical resection (10.9%), repeated transarterial chemoembolization (TACE) (42.5%), and conservative management (42.9%). Among the patients with obstructive jaundice (n=88), successful biliary drainage was associated with better overall survival rate. Among the patients with BCLC stage C, overall survival differed depending on the initial treatment for HCC; surgical resection, TACE, systemic chemotherapy, and conservative management showed overall survival rates of 11.5, 6.0 ,2.4, and 1.6 months, respectively. After adjusting for confounders, surgical resection and repeated TACE were significant prognostic factors for HCC patients with bile duct invasion (hazard ratios 0.47 and 0.39, Ps <0.001, respectively).
Conclusions
The survival of HCC patients with bile duct invasion at initial diagnosis is generally poor. However, aggressive treatments for HCC such as resection or biliary drainage may be beneficial therapeutic options for patients with preserved liver function.

Citations

Citations to this article as recorded by  Crossref logo
  • Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
    Wenzhe Fan, Xinlin Zheng, Weihong Zhang, Bowen Zhu, Yanqin Wu, Miao Xue, Rong Tang, Zhen Huang, Liangliang Qiao, Mingjian Lu, Jian Wu, Yiyang Tang, Jinghua Chen, Shugui Huang, Mingjun Bai, Jiaping Li
    Journal of Hepatocellular Carcinoma.2025; Volume 12: 615.     CrossRef
  • PBK as a novel biomarker performed excellent diagnostic and prognostic value in HCC associated with immune infiltration and methylation
    Beibei Lv, Fenna Zhang, Xinyi Zhang, Ziyi Wang, Shuai Hao, Na Ye, Na He
    Journal of Molecular Histology.2025;[Epub]     CrossRef
  • Efficacy and safety of endoscopic ultrasound-guided hepaticogastrostomy for biliary drainage in hypervascular hepatocellular carcinoma: a retrospective study from Japan
    Kenneth Tachi, Kazuo Hara, Nozomi Okuno, Shin Haba, Takamichi Kuwahara, Toshitaka Fukui, Ahmed Mohammed Sadek, Hossam El-Din Shaaban Mahmoud Ibrahim, Minako Urata, Takashi Kondo, Yoshitaro Yamamoto
    Clinical Endoscopy.2025; 58(3): 448.     CrossRef
  • Liver transplantation for spalt-like transcription factor 4-positive dual-phenotype hepatocellular carcinoma with microscopic bile duct tumor thrombus: a case report
    Songming Ding, Xiangyan Liu, Zhuoyi Wang, Shanjie Dong, Qinfen Xie, Shusen Zheng, Qiyong Li
    Endoscopy.2025; 57(S 01): E804.     CrossRef
  • Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report
    Yudai Sato, Tomoko Tadokoro, Hiroki Yamana, Hiraki Akai, Kei Takuma, Naoki Fujita, Mai Nakahara, Kyoko Oura, Koji Fujita, Joji Tani, Hideki Kamada, Asahiro Morishita, Hideki Kobara, Seiko Kagawa, Reiji Haba, Keiichi Okano, Tsutomu Masaki
    DEN Open.2024;[Epub]     CrossRef
  • Transarterial Therapy for Hepatocellular Carcinoma Invading the Bile Duct
    Shiro Miyayama
    Interventional Radiology.2024; 9(1): 1.     CrossRef
  • Outcomes of jaundice in advanced hepatocellular carcinoma – a sub-Saharan perspective
    PB Keshaw, M Bernon, M Emmamally, R Khan, UK Kotze, R Segobin, D Creamer, JEJ Krige, E Jonas, S Sobnach
    South African Journal of Surgery.2024; 62(2): 108.     CrossRef
  • CORRECTION OF BILIARY HYPERTENSION IN THE TREATMENT OF PATIENTS WITH MECHANICAL JAUNDICE
    V. V. Boyko, Р. M. Smachilo, А. V. Maloshtan, V. M. Likhman, V. Yu. Brovkin
    Kharkiv Surgical School.2024; (1): 29.     CrossRef
  • The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion
    Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Koji Fujita, Tsutomu Masaki, Hideki Kobara
    Cancers.2024; 16(14): 2534.     CrossRef
  • DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis
    Wenzhe Fan, Xinlin Zheng, Xiao Zhao, Bowen Zhu, Yanqin Wu, Miao Xue, Rong Tang, Zhen Huang, Liangliang Qiao, Mingjian Lu, Yiyang Tang, Jian Wu, Jiaping Li
    Cancer Medicine.2024;[Epub]     CrossRef
  • Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion
    Keungmo Yang, Hyun Yang, Chang Wook Kim, Hee Chul Nam, Ji Hoon Kim, Ahlim Lee, U Im Chang, Jin Mo Yang, Hae Lim Lee, Jung Hyun Kwon, Soon Woo Nam, Soon Kyu Lee, Pil Soo Sung, Ji Won Han, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hee Ye
    Gut and Liver.2024; 18(5): 877.     CrossRef
  • Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B–C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea
    Chai Hong Rim, Won Sup Yoon, Sunmin Park
    Oncology.2024; : 1.     CrossRef
  • Efficacy Analysis of PTCD + TACE vs PTCD + Apatinib in the Treatment of HCC with Obstructive Jaundice: A Retrospective Study
    Haohao Lu, Bin Liang, Xiangwen Xia, Chuansheng Zheng
    Anti-Cancer Agents in Medicinal Chemistry.2024; 24(17): 1241.     CrossRef
  • Effect of Biliary Tract Invasion with Obstructive Jaundice on the Prognosis of Patients With Unresectable Hepatocellular Carcinoma
    Weiwei Jiang, Xiaobo Fu, Guobao Wang, Han Qi, Zixiong Chen, Fei Gao
    Academic Radiology.2023; 30(3): 483.     CrossRef
  • Effect of percutaneous stenting strategy of unresectable malignant hilar biliary obstruction by three‐dimensional reconstruction volumetry
    Xiaobo Fu, Weiwei Jiang, Maoyuan Mu, Guobao Wang, Han Qi, Zixiong Chen, Mengxuan Zuo, Fei Gao
    Cancer Medicine.2023; 12(8): 9506.     CrossRef
  • Multimodality imaging approach in identifying invasive hepatocellular carcinoma
    Neel Shroff, Woongsoon Choi, Mohamed Elshikh, Brian Wong, Peeyush Bhargava
    Clinical Imaging.2023; 97: 34.     CrossRef
  • Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study
    Qizhen Huang, Kongying Lin, Zhipeng Lin, Hongbin Ji, Xiaoyu Zhou, Bin Wang, Yufeng Chen, Chuandong Sun, Shuguo Zheng, Jinhong Chen, Yifan Wang, Yanming Zhou, Weiping Zhou, Yongyi Zeng
    Cancer Medicine.2023; 12(22): 20821.     CrossRef
  • Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
    Osman Öcal, Michael Ingrisch, Muzaffer Reha Ümütlü, Bora Peynircioglu, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Christoph J. Zech, Christian Sengel, Irene Bargellini, Roberto Iezzi, Alberto Benito, Maciej Pech, Peter Malfer
    British Journal of Cancer.2022; 126(2): 211.     CrossRef
  • Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis
    Zhen-Hua Chen, Jin-Kai Feng, Ju-Xian Sun, Jia-Yi Wu, Wei-Xing Guo, Jie Shi, Yong-Gang Wei, Jian-Yin Zhou, Zhi-Bo Zhang, Mao-Lin Yan, Shu-Qun Cheng
    HPB.2022; 24(4): 547.     CrossRef
  • Hepatocellular Carcinoma with Hepatic Duct Tumor Thrombus
    Shih-Feng Huang, Cheng-Chung Tsai
    Indian Journal of Surgery.2022; 84(S2): 434.     CrossRef
  • Transarterial chemoembolization for hepatocellular carcinoma with vascular invasion
    Shiro Miyayama, Yasuaki Arai, Osamu Matsui
    The British Journal of Radiology.2022;[Epub]     CrossRef
  • Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion
    Ching-Hsin Lee, An-Hsin Chen, Sheng-Ping Hung, Cheng-En Hsieh, Jeng-Hwei Tseng, Po-Jui Chen, Jen-Yu Cheng, Joseph Tung-Chieh Chang, Kun-Ming Chan, Shi-Ming Lin, Chen-Chun Lin, Wei-Ting Chen, Wan-Yu Chen, Bing-Shen Huang
    Cancers.2022; 14(7): 1616.     CrossRef
  • Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study
    Haofan Wang, Yitao Mao, Chunning Zhang, Xiaojun Hu, Bin Chen, Luwen Mu, Shuyi Wang, Yifen Lin, Zhanwang Xiang, Mingsheng Huang
    Liver Research.2022; 6(4): 269.     CrossRef
  • Cholangioscopic biopsy sample detection of bile duct invasion by hepatocellular carcinoma: an underappreciated entity
    Teddy Sutardji Nagaria, Isaac Raijman, Mohamed O. Othman, Gary Lloyd Horn, John M. Vierling, Juhi Mahadik, Sadhna Dhingra
    iGIE.2022; 1(1): 62.     CrossRef
  • Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma: a retrospective multicenter study
    Akihiro Matsumi, Hironari Kato, Toru Ueki, Etsuji Ishida, Masahiro Takatani, Masakuni Fujii, Masaki Wato, Tatsuya Toyokawa, Ryo Harada, Hirofumi Tsugeno, Minoru Matsubara, Hiroshi Matsushita, Hiroyuki Okada
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Hepatocellular carcinoma recurrence in the extrahepatic bile duct wall: A case report
    Taku Matsumoto, Toshihiko Yoshida, Takashi Yamagishi, Hironobu Goto, Dai Otsubo, Akinobu Furutani, Hisoka Yamane, Yasuhiro Fujino, Masahiro Tominaga
    Clinical Case Reports.2021; 9(3): 1561.     CrossRef
  • A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma
    Jun-Yi Wu, Ju-Xian Sun, Jia-Yi Wu, Xiao-Xiao Huang, Yan-Nan Bai, Yong-Yi Zeng, Zhi-Bo Zhang, Shu-Qun Cheng, Mao-Lin Yan
    BMC Cancer.2021;[Epub]     CrossRef
  • Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study
    Jin-Kai Feng, Ju-Xian Sun, Zong-Han Liu, Jing-Wen Gu, Zhen-Hua Chen, Chang Liu, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng
    Cancer Management and Research.2021; Volume 13: 3551.     CrossRef
  • Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study
    Qizhen Huang, Yufeng Chen, Kongying Lin, Chuandong Sun, Shuguo Zheng, Jinhong Chen, Yifan Wang, Yanming Zhou, Weiping Zhou, Jingfeng Liu, Yongyi Zeng
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • The Model to Estimate Survival in Ambulatory Hepatocellular Carcinoma Patients Aids in the Decision for TACE Retreatment
    Young Youn Cho, Su Jong Yu, Jung-Ju Yoo, Minjong Lee, Dong Hyeon Lee, Yuri Cho, Kyoung Wan Yoon, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
    Journal of Clinical Gastroenterology.2020; 54(4): 370.     CrossRef
  • Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study


    Qizhen Huang, Kongying Lin, Lei Wang, Jianxing Zeng, Hongzhi Liu, Zongren Ding, Yongyi Zeng, Jingfeng Liu
    Cancer Management and Research.2020; Volume 12: 9183.     CrossRef
  • Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells
    Changying Shi, Jiamei Yang, Longmiao Hu, Boyi Liao, Liang Qiao, Weifeng Shen, Feng Xie, Guoqing Zhu
    Aging.2020; 12(15): 15546.     CrossRef
  • Triple Covered Metal Stent Deployment Using Side-by-Side Technique for Hemobilia due to Hepatocellular Carcinoma (with Video)
    Takeshi Ogura, Tadahiro Yamada, Masanori Yamada, Saori Ueno, Kazuhide Higuchi
    Digestive Diseases.2020; 38(4): 348.     CrossRef
  • Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion
    Taku Tanaka, Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro
    Oncology.2020; 98(9): 621.     CrossRef
  • FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus
    Wei Zhang, Cheng Fang, Huipan Liu, Yue Chen
    Clinical Nuclear Medicine.2019; 44(2): 130.     CrossRef
  • Outcomes of major laparoscopic liver resection for hepatocellular carcinoma
    Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Sungho Kim, Kilhwan Kim, In Gun Hyun
    Surgical Oncology.2018; 27(1): 31.     CrossRef
  • Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma
    Hyun Pyo Hong, Kyungmin Park
    International Journal of Gastrointestinal Intervention.2018; 7(2): 85.     CrossRef
  • 12,528 View
  • 252 Download
  • 44 Web of Science
  • Crossref

Case Report

Viral hepatitis

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song
Clin Mol Hepatol 2016;22(3):396-399.
Published online August 30, 2016
DOI: https://doi.org/10.3350/cmh.2015.0039
Autochthonous hepatitis E virus (HEV) is an emerging pathogen in developed countries, and several cases of acute HEV infection have been reported in South Korea. However, there have been no reports on HEV-associated Guillain-Barré syndrome (GBS) in Korea. We recently experienced the case of a 58-year-old Korean male with acute HEV infection after ingesting raw deer meat. Persistent cholestasis was resolved by the administration of prednisolone. At 2.5 months after the clinical presentation of HEV infection, the patient developed weakness of the lower limbs, and was diagnosed with GBS associated with acute hepatitis E. To our knowledge, this is the second report on supportive steroid therapy for persistent cholestasis due to hepatitis E, and the first report of GBS in a Korean patient with acute HEV infection.

Citations

Citations to this article as recorded by  Crossref logo
  • Therapeutic Options for the Management of the Cholestatic Phase of Viral Hepatitis A and E—A Systematic Review
    Suprabhat Giri, Gaurav Khatana, Prasanna Gore, Dibya L. Praharaj, Anand V. Kulkarni, Anil C. Anand
    Journal of Clinical and Experimental Hepatology.2025; 15(5): 102557.     CrossRef
  • Cholestasis in hepatitis E virus infection
    Tatsuo Kanda, Reina Sasaki-Tanaka, Takeshi Yokoo, Kazunao Hayashi, Hiroteru Kamimura, Atsunori Tsuchiya, Shuji Terai
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Neurological manifestations of hepatitis E virus infection: An overview
    Ashish Kumar Jha, Gaurav Kumar, Vishwa Mohan Dayal, Abhay Ranjan, Arya Suchismita
    World Journal of Gastroenterology.2021; 27(18): 2090.     CrossRef
  • Hepatitis E virus‐associated Guillain–Barre syndrome: Revision of the literature
    Hang Liu, Ying Ma
    Brain and Behavior.2020;[Epub]     CrossRef
  • A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection
    Prashanth Rawla, Jeffrey Pradeep Raj, Alan Jose Kannemkuzhiyil, John Sukumar Aluru, Krishna Chaitanya Thandra, Mahesh Gajendran
    Medical Sciences.2020; 8(1): 9.     CrossRef
  • Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Meegun Hong, Dae Hee Han, Jitaek Hong, Dong Joon Kim, Ki Tae Suk
    Probiotics and Antimicrobial Proteins.2019; 11(2): 335.     CrossRef
  • Guillain-Barré syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review
    Manish Chandra Choudhary, Vijeta Bajpai, Lovkesh Anand, Ekta Gupta
    Intractable & Rare Diseases Research.2019; 8(1): 43.     CrossRef
  • Hepatitis E Virus: Epidemiology, Diagnosis, and Management
    Nae-Yun Heo
    The Korean Journal of Gastroenterology.2019; 74(3): 130.     CrossRef
  • Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review
    Xiaoqin Zheng, Liang Yu, Qiaomai Xu, Silan Gu, Lingling Tang
    BMC Infectious Diseases.2018;[Epub]     CrossRef
  • Hiding in Plain Sight? It’s Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries
    Nicola J. King, Joanne Hewitt, Anne-Marie Perchec-Merien
    Food and Environmental Virology.2018; 10(3): 225.     CrossRef
  • 22,095 View
  • 123 Download
  • 8 Web of Science
  • Crossref
Original Articles

Viral hepatitis

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim
Korean J Hepatol 2013;19(1):45-50.
Published online March 25, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.1.45
Background/Aims

The distribution of hepatitis C virus (HCV) genotypes varies geographically. In Korea, genotypes 1 and 2 comprise more than 90% of HCV infections, while genotype 6 is very rare. This study compared the clinical and epidemiological characteristics of patients with genotype 6 HCV infection with those infected with HCV genotypes 1 and 2.

Methods

This was a prospective, multicenter HCV cohort study that enrolled 1,173 adult patients, of which 930 underwent HCV genotype analysis, and only 9 (1.0%) were found to be infected with genotype 6 HCV. The clinical and epidemiological parameters of the genotypes were compared.

Results

The patients with genotype 6 HCV had a mean age of 41.5 years, 77.8% were male, and they had no distinct laboratory features. A sustained virologic response (SVR) was observed in four (67%) of six patients who received antiviral therapy. Risk factors such as the presence of a tattoo (n=6, 66.7%), more than three sexual partners (n=3, 33.3%), and injection drug use (n=3, 33.3%) were more common among genotype 6 patients than among genotypes 1 or 2.

Conclusions

The epidemiology and treatment response of patients infected with genotype 6 HCV differed significantly from those with genotypes 1 or 2, warranting continuous monitoring.

Citations

Citations to this article as recorded by  Crossref logo
  • 2025 KASL clinical practice guidelines for management of hepatitis C
    Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
    Clinical and Molecular Hepatology.2026; 32(1): 1.     CrossRef
  • Characterization of Incident Hepatitis C Virus Infection among People Living with HIV in a HIV Clinic in Korea
    BumSik Chin, Yeonjae Kim, Gayeon Kim, Jaehyun Jeon, Min-Kyung Kim, Jae Yoon Jeong, Hyeokchoon Kwon, Seongwoo Nam
    Infection & Chemotherapy.2024; 56(4): 544.     CrossRef
  • Analysis of Hepatitis C Virus Genotypes and RNA Quantitative Values in Cheonan, Republic of Korea from 2007 to 2016
    Bishguurmaa Renchindorj, Bo Kyeung Jung, Joowon Park
    Microbiology and Biotechnology Letters.2022; 50(3): 422.     CrossRef
  • Systematic review: epidemiology and response to direct‐acting antiviral therapy in genotype 6 chronic hepatitis C virus infection
    Panita Mettikanont, Chalermrat Bunchorntavakul, K. Rajender Reddy
    Alimentary Pharmacology & Therapeutics.2019; 49(5): 492.     CrossRef
  • Analysis of HCV RNA Genotypes and Quantitative Values of Korean HCV NAT Reactive Blood Donors
    Sunmi Shin, Jae-won Kang, Jungwon Kang, Young Ik Seo, Jung Ran Park, Dae Dong Lee, Hyukki Min, Myunghan Kim
    The Korean Journal of Blood Transfusion.2019; 30(3): 205.     CrossRef
  • Molecular characterization of hepatitis C virus genotype 6 subtypes in Thai blood donors
    Anchalee Sistayanarain, Suriya Chaiwong
    Journal of Microbiology, Immunology and Infection.2017; 50(1): 26.     CrossRef
  • Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
    Su Rin Shin, Young Seok Kim, Young-Seok Lim, June Sung Lee, Jin Woo Lee, Sun Myung Kim, Sook-Hyang Jeong, Joo Hyun Sohn, Myung Seok Lee, Sang Hoon Park
    Gut and Liver.2017; 11(2): 270.     CrossRef
  • Public participation in decision-making on the coverage of new antivirals for hepatitis C
    Katharina Kieslich, Peter Littlejohns and Albert Weale, Katharina Kieslich, Jeonghoon Ahn, Gabriele Badano, Kalipso Chalkidou, Leonardo Cubillos, Renata Curi Hauegen, Chris Henshall, Carleigh B Krubiner, Peter Littlejohns, Lanting Lu, Steven D Pearson, An
    Journal of Health Organization and Management.2016; 30(5): 769.     CrossRef
  • The Applications of Hepatitis C Virus (HCV) Replication System in Developing Anti-HCV Reagents
    Hyosun Cho
    Journal of Bacteriology and Virology.2015; 45(2): 171.     CrossRef
  • Epidemiology of Hepatitis C Virus Infection in Korea
    Sook-Hyang Jeong
    Korean Journal of Medicine.2015; 88(6): 630.     CrossRef
  • Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
    Seung Kak Shin, Soo Yong Park, Young Kul Jung, Eui Joo Kim, Heon Nam Lee, Jong Joon Lee, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    The Korean Journal of Gastroenterology.2015; 65(2): 105.     CrossRef
  • Current Treatment Options in Patients with Hepatitis C Virus Genotype 6
    Nghia H. Nguyen, Mindie H. Nguyen
    Gastroenterology Clinics of North America.2015; 44(4): 871.     CrossRef
  • Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
    Nghia H. Nguyen, Shelley A. McCormack, Philip Vutien, Brittany E. Yee, Pardha Devaki, David Jencks, Mindie H. Nguyen
    Intervirology.2015; 58(1): 27.     CrossRef
  • Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks
    Nghia H. Nguyen, Shelley A. McCormack, Brittany E. Yee, Pardha Devaki, David Jencks, David T. Chao, Mindie H. Nguyen
    Hepatology International.2014; 8(4): 540.     CrossRef
  • 10,714 View
  • 95 Download
  • Crossref

Artificial intelligence, epidemiology, methodology, or others

Type and cause of liver disease in Korea: single-center experience, 2005-2010
Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Yeo Myung Kim, Ho Gil, Bo-Young Min, Mun Hyuk Seong, Eun Sun Jang, Jin-Wook Kim
Korean J Hepatol 2012;18(3):309-315.
Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.309
Background/Aims

The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May 2010.

Methods

A cohort of patients who visited the liver clinic of the hospital during the aforementioned time period were consecutively enrolled (n=6,307). Consistent diagnostic criteria for each liver disease were set by a single, experienced hepatologist, and the diagnosis of all of the enrolled patients was confirmed by retrospective review of their medical records.

Results

Among the 6,307 patients, 528 (8.4%) were classified as acute hepatitis, 3,957 (62.7%) as chronic hepatitis, 767 (12.2%) as liver cirrhosis, 509 (8.1%) as primary liver cancer, and 546 (8.7%) as a benign liver mass or other diseases. The etiologies in the acute hepatitis group in decreasing order of prevalence were hepatitis A (44.3%), toxic hepatitis (32.4%), other hepatitis viruses (13.8%), and cryptogenic hepatitis (9.1%). In the chronic hepatitis group, 51.2% of cases were attributed to viral hepatitis, 33.3% to nonalcoholic fatty liver disease, and 13.0% to alcoholic liver disease (ALD). Of the cirrhoses, 73.4% were attributable to viral causes and 18.1% to alcohol. Of the hepatocellular carcinoma cases, 86.6% were attributed to viral hepatitis and 11.6% to ALD. Among the benign tumors, hemangioma comprised 52.2% and cystic liver disease comprised 33.7%.

Conclusions

Knowledge of the current status of the type and cause of liver disease in Korea may be valuable as a basis for evaluating changing trends in liver disease in that country.

Citations

Citations to this article as recorded by  Crossref logo
  • 15-Year Long-Term Follow-Up on the Progression to Liver Cancer in a Patient with Alcoholic Hepatitis Who Continued Drinking: A Case Report and Clinical Approach
    Nahyun Cho, Hye-ri Bae, Nam-hun Lee
    The Journal of Internal Korean Medicine.2024; 45(4): 823.     CrossRef
  • Classification and Epidemiologic Aspects of Acute-on-Chronic Liver Failure
    Zaid H. Tafesh, Raquel Olivo Salcedo, Nikolaos T. Pyrsopoulos
    Clinics in Liver Disease.2023; 27(3): 553.     CrossRef
  • Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
    Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
    Medicina.2023; 59(8): 1436.     CrossRef
  • Pharmacological Benefits and Underlying Mechanisms of Salvia miltiorrhiza against Molecular Pathology of Various Liver Diseases: A Review
    Cho Hyun Hwang, Eungyeong Jang, Jang-Hoon Lee
    The American Journal of Chinese Medicine.2023; 51(07): 1675.     CrossRef
  • Diagnosis of Cystic Hepatic Lesions on Ultrasonography
    Eun Jeong Choi, Jun Sik Yoon
    Clinical Ultrasound.2023; 8(2): 59.     CrossRef
  • Gall Bladder Stones Formation in Patients with Breast Cancer on Tamoxifen Therapy in Iraqi Female
    Israa Jarjees Rasheed Saeed, Ali Mohsin Hasan
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 517.     CrossRef
  • Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults
    In Rae Cho, Sang-Wook Yi, Ja Sung Choi, Jee-Jeon Yi
    Cancers.2022; 14(7): 1709.     CrossRef
  • Cost-effectiveness of chronic hepatitis C screening and treatment
    Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim
    Clinical and Molecular Hepatology.2022; 28(2): 164.     CrossRef
  • Epidemiology of liver failure in Asia‐Pacific region
    Ankur Jindal, Shiv K. Sarin
    Liver International.2022; 42(9): 2093.     CrossRef
  • Which vendor is most cited in the hepatic imaging literature?
    Roya Rezvani Habibabadi, Joseph H. Huntley, Rozita Jalilianhasanpour, David M. Yousem
    Clinical Imaging.2021; 71: 39.     CrossRef
  • Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S1.     CrossRef
  • Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
    Shiv K Sarin, Manoj Kumar, Mohammed Eslam, Jacob George, Mamun Al Mahtab, Sheikh M Fazle Akbar, Jidong Jia, Qiuju Tian, Rakesh Aggarwal, David H Muljono, Masao Omata, Yoshihiko Ooka, Kwang-Hyub Han, Hye Won Lee, Wasim Jafri, Amna S Butt, Chern H Chong, Se
    The Lancet Gastroenterology & Hepatology.2020; 5(2): 167.     CrossRef
  • Bile duct ligation of C57BL/6 mice as a model of hepatic encephalopathy
    Inja Cho, Bon-Nyeo Koo, Eun Hee Kam, Su Kyoung Lee, Hanseul Oh, So Yeon Kim
    Anesthesia and Pain Medicine.2020; 15(1): 19.     CrossRef
  • Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography
    ByukGyung Choi, In Young Choi, Sang Hoon Cha, Suk Keu Yeom, Hwan Hoon Chung, Seung Hwa Lee, Jaehyung Cha, Ju-Han Lee
    Japanese Journal of Radiology.2020; 38(12): 1179.     CrossRef
  • Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    Gut and Liver.2020; 14(6): 775.     CrossRef
  • Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in Korea
    Sang Soo Lee, Cha Young Kim, Bo Ra Kim, Ra Ri Cha, Wan Soo Kim, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok‐Jae Lee
    Journal of Viral Hepatitis.2019; 26(4): 459.     CrossRef
  • The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta‐analysis of 24,147 subjects
    Xinpei Chen, Pengcheng Zhou, Luo De, Bo Li, Song Su
    Molecular Genetics & Genomic Medicine.2019;[Epub]     CrossRef
  • Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
    Eun Sun Jang, Kyung‐Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook‐Hyang Jeong
    Journal of Medical Virology.2019; 91(12): 2158.     CrossRef
  • Harmful algal blooms and liver diseases: focusing on the areas near the four major rivers in South Korea
    Seungjun Lee, Jinnam Kim, Boseung Choi, Gijung Kim, Jiyoung Lee
    Journal of Environmental Science and Health, Part C.2019; 37(4): 356.     CrossRef
  • Analysis of HCV RNA Genotypes and Quantitative Values of Korean HCV NAT Reactive Blood Donors
    Sunmi Shin, Jae-won Kang, Jungwon Kang, Young Ik Seo, Jung Ran Park, Dae Dong Lee, Hyukki Min, Myunghan Kim
    The Korean Journal of Blood Transfusion.2019; 30(3): 205.     CrossRef
  • Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
    Jungyeon Kim, Markus Haacker, Salmaan Keshavjee, Rifat Atun
    BMJ Global Health.2019; 4(3): e001441.     CrossRef
  • DETECTION OF TUMOR NECROSIS FACTOR- (TNF- ) GENE PROMOTERS POLYMORPHISM AMONG LIVER CIRRHOSIS PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION IN SURABAYA, INDONESIA
    Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Budi Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Boedi Setiawan, Maria Inge Lusida, Soetjipto Soetjipto, Retno Handajani
    Indonesian Journal of Tropical and Infectious Disease.2019; 7(5): 115.     CrossRef
  • Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection
    Jung Wha Chung, Eun Shin, Haeryoung Kim, Ho‐Seong Han, Jai Young Cho, Young Rok Choi, Sukho Hong, Eun Sun Jang, Jin‐Wook Kim, Sook‐Hyang Jeong
    Liver International.2018; 38(5): 903.     CrossRef
  • Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea
    Hogil Kim, Yun Kyung Chung, Inah Kim
    Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
  • Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea
    Sook-Hyang Jeong
    Clinical and Molecular Hepatology.2018; 24(1): 10.     CrossRef
  • Epidemiology of alcoholic liver disease in Korea
    Jae Young Jang, Dong Joon Kim
    Clinical and Molecular Hepatology.2018; 24(2): 93.     CrossRef
  • Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents
    Jinmin Jung, Jae Hyun Kwon, Gi-Won Song, Eun-Young Tak, Vavara A. Kirchner, Sung-Gyu Lee
    Journal of Gastrointestinal Surgery.2018; 22(8): 1334.     CrossRef
  • Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea
    Sang‐Wook Yi, Ja‐Sung Choi, Jee‐Jeon Yi, Yong‐ho Lee, Ki Jun Han
    Cancer.2018; 124(13): 2748.     CrossRef
  • Seropositivity of Hepatitis C Virus among Persons affected Leprosy in Korea
    Jong-Pill Kim, Kuk-Hyeong Kang, Jin-Mo Park
    Korean Leprosy Bulletin.2018; 51(1): 13.     CrossRef
  • Outcome analysis of hip or knee arthroplasty in patients with cirrhotic liver disease
    Young-Jun Seol, Taek-Rim Yoon, Dong-Hyun Lee, Sun-Ho Lee, Kyung-Soon Park
    Journal of Orthopaedics.2017; 14(1): 171.     CrossRef
  • Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
    Cha Young Kim, Bo Ra Kim, Sang Soo Lee, Dae-Hong Jeon, Chang Min Lee, Wan Soo Kim, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok-Jae Lee
    Medicine.2017; 96(2): e5844.     CrossRef
  • Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea
    Bo Hyun Kim, Hwa Young Choi, Moran Ki, Kyung-Ah Kim, Eun Sun Jang, Sook-Hyang Jeong, Ming-Lung Yu
    PLOS ONE.2017; 12(8): e0182391.     CrossRef
  • Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
    Abbaszadeh Sepideh, Parastouei Karim, Afshari Hossein, Rostami Leila, Mahmoudi Hamdollah, Ghamarchehreh Mohammad E, Sepandi Mojtaba, Samadi Mohammad, Ghanizadeh Ghader, Alavian Seyed Moayed
    Journal of the American College of Nutrition.2016; 35(6): 500.     CrossRef
  • The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
    Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
    Clinical and Molecular Hepatology.2016; 22(2): 241.     CrossRef
  • Economic Burden of Hepatitis in South Korea
    Hugh Watson, Pascal Minini, Jeffrey Encinas
    Japanese Journal of Infectious Diseases.2016; 69(4): 354.     CrossRef
  • Illness Experience of Patients with Chronic Hepatitis C Participating in Clinical Trials
    Hoo-Jeung Cho, Euna Park
    Osong Public Health and Research Perspectives.2016; 7(6): 394.     CrossRef
  • Recent outbreaks of hepatitis C virus infection in Korea and strategy for prevention
    In Hee Kim
    Journal of the Korean Medical Association.2016; 59(12): 912.     CrossRef
  • Recent outbreaks of hepatitis C virus infection in Korea and strategy for prevention
    In Hee Kim
    Journal of the Korean Medical Association.2016; 59(12): 912.     CrossRef
  • Prospective cohort study on the outcomes of hepatitis C virus‐related cirrhosis in South Korea
    Sang Soo Lee, Sook‐Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Si Hyun Bae, Han Chu Lee, Mee‐Kyung Kee, Chun Kang
    Journal of Gastroenterology and Hepatology.2015; 30(8): 1281.     CrossRef
  • New direct-acting antivirals for the treatment of chronic hepatitis C
    Sook-Hyang Jeong
    Journal of the Korean Medical Association.2015; 58(12): 1154.     CrossRef
  • Health Screening among HBV Carriers in the Korean National Health and Nutrition Examination Survey V (KNHANES V)
    Hyung Eun Son, Sun Jae Jung, Aesun Shin
    Asian Pacific Journal of Cancer Prevention.2015; 16(9): 3653.     CrossRef
  • Epidemiology of Hepatitis C Virus Infection in Korea
    Sook-Hyang Jeong
    Korean Journal of Medicine.2015; 88(6): 630.     CrossRef
  • Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors
    Jeong-Yeop Song, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Soo Ji Jin, Jung Mi Park, Gyu Seong Choi, Jun Chul Chung, Min Hee Lee, Youn Hee Cho, Moon Han Choi, Dong Choon Kim, Hyun Jong Choi, Jong Ho Moon, Se Hwan Lee, Seung Won Jeong, Jae Young Jang, H
    Nuclear Medicine Communications.2015; 36(4): 319.     CrossRef
  • Factors associated with significant liver fibrosis assessed using transient elastography in general population
    Seng Chan You
    World Journal of Gastroenterology.2015; 21(4): 1158.     CrossRef
  • Clinical Features and Risk Factors for Severe Complications among Patients with Acute Hepatitis A Virus Infection in The Jeonbuk Province of Korea
    Sun Ho Yoo, In Hee Kim, Ji Won Jang, Chung Hwan Choi, Jin Chang Moon, Jin Kyoung Park, Sang Youn Lee, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Eun Young Cho, Gum Mo Jung
    The Korean Journal of Gastroenterology.2014; 63(1): 25.     CrossRef
  • Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesis
    Nabeen C. Nayak
    Current Medicine Research and Practice.2014; 4(2): 62.     CrossRef
  • Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
    Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
    Clinical and Molecular Hepatology.2014; 20(3): 274.     CrossRef
  • Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
    Joo Lee, Simonetta Friso, Sang-Woon Choi
    Nutrients.2014; 6(8): 3303.     CrossRef
  • The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
    Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon
    Clinical and Molecular Hepatology.2014; 20(1): 47.     CrossRef
  • Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat
    So Hyung Hong, Ki Tae Suk, Sang Hyeon Choi, Jung Wook Lee, Ho Taik Sung, Chang Hoon Kim, Eun Ji Kim, Myoung Jo Kim, Sang Hak Han, Moon Young Kim, Soon Koo Baik, Dong Joon Kim, Gyoung-Ja Lee, Sang-kyu Lee, Seung Ha Park, Ohk Hyun Ryu
    Food and Chemical Toxicology.2013; 55: 586.     CrossRef
  • HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
    Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
    Clinical and Molecular Hepatology.2013; 19(4): 409.     CrossRef
  • 12,870 View
  • 106 Download
  • Crossref